BioSpace News Archive

Zebra Medical Vision, the deep-learning medical imaging analytics company, announces today its seventh FDA clearance.

Biocom California, the association representing the California life science industry, today announced the winners of its fifth annual Life Science Catalyst Awards . The awards celebrate the accomplished and up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers

City of Hope doctors participated in research presented at the American Society of Hematology (ASH) virtual meeting, Dec. 5 to 8, that are helping advance the treatment of blood cancers, including one study which demonstrated allogeneic stem cell transplants do have a survival benef

More than a million people in the U.S. rely on others to complete simple tasks such as brushing teeth, eating, and opening doors, because of neuromuscular disorders caused by Muscular Dystrophy, Multiple Sclerosis, Spinal Cord Injury, and other conditions.

Exactech , a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today the first ankle replacement procedure using the Vantage® Ankle PSI , patient-specific surgical planning and 3D-printed instruments. Manufactured by Rock Hill, South Carolina-based

Maternal Infant Health Insights and Cognitive Intelligence (MIHIC) is the World’s First Artificial Intelligence (AI) Platform to Predict the Propensity of 48 Maternal, Fetal and Infant Health Risks Early

Genetic mutations linked with cancer can occur during childhood or even before birth and proliferate in the body for many years before causing cancer symptoms, according to a new study.

Wolters Kluwer, Health , a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx™ , a Tabula Rasa Healthcare precision dosing solution, with Sentri7’s Antimicrobial Stewardship (AMS) solution. With a single

Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, today announced that Charles Huiner has been named President and Chief Executive Officer (CEO)

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273.